-transparent.png){kind=logo}
Nonmedullary thyroid carcinoma is known to occur in association with primary hyperparathyroidism. A combination of secondary, uremic, hyperparathyroidism and non-medullary thyroid carcinoma is rare and was hitherto reported in only 12 cases. We report another three patients with this parathyroid/thyroid disease combination, suggesting that it may represent not merely a coincidence. A number of factors active in secondary hyperparathyroidism may play a role in the induction and/or promotion of the thyroid cancer. These include parathyroid endocrinopathy, goiterogenic effect of prolonged hypercalcemia, and uremia. During surgery on the parathyroid glands, associated thyroid lesions demand special considerations.
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
March 1982,
American journal of surgery,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
September 2013,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
January 1985,
International surgery,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
February 2003,
Clinical nuclear medicine,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
November 2016,
Medical science monitor : international medical journal of experimental and clinical research,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
October 2000,
Current treatment options in oncology,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
July 2005,
The Laryngoscope,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
July 2000,
Nihon rinsho. Japanese journal of clinical medicine,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
June 2005,
Thyroid : official journal of the American Thyroid Association,
E Nash, and
S Eldar, and
I Shajrawi, and
J Abrahamson, and
M Schein
January 1991,
Oncology,
